Alpha Tau Medical (DRTS) Net Income towards Common Stockholders (2021 - 2026)

Alpha Tau Medical has disclosed Net Income towards Common Stockholders across 6 years of filings, most recently posting $23.0 million for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at $23.0 million, up 170.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.8 million (up 76.24% YoY), and the FY2025 annual result was $42.4 million, up 33.55% from the prior year.
• Net Income towards Common Stockholders came in at $23.0 million for Q1 2026 at Alpha Tau Medical, up from $12.2 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $25.7 million in Q1 2022 to a low of $2.0 million in Q2 2022.
• The 5-year median for Net Income towards Common Stockholders is $8.1 million (2023), against an average of $9.4 million.
• Across the five-year window, Net Income towards Common Stockholders sank 71.42% in 2022 and jumped 334.88% in 2023, its largest moves.
• Alpha Tau Medical's Net Income towards Common Stockholders stood at $3.4 million in 2022, then jumped by 116.78% to $7.3 million in 2023, then rose by 28.89% to $9.5 million in 2024, then rose by 28.86% to $12.2 million in 2025, then jumped by 88.02% to $23.0 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $23.0 million (Q1 2026), $12.2 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.